Neutrophil chemotactic activity in bronchoalveolar lavage fluid of patients with AIDS-associated Pneumocystis carinii pneumonia

Scandinavian Journal of Infectious Diseases

Volumn 29, Issue 4, 1997, Pages 367-371

  Benfield, Thomas L ^a,d   Kharazmi, Arsalan ^b   Larsen, Christian Grønhøj ^c   Lundgren, Jens D ^a  

^a HVIDOVRE HOSPITAL   (Denmark)

^b Rigshospitalet   (Denmark)

^c AARHUS UNIVERSITY HOSPITAL   (Denmark)

^d UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; INTERLEUKIN 8;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CELL INFILTRATION; CLINICAL ARTICLE; HUMAN; HUMAN CELL; INFLAMMATION; INFLAMMATORY CELL; LUNG LAVAGE; LUNG PARENCHYMA; LYMPHOCYTE; MACROPHAGE; NEUTROPHIL; NEUTROPHIL CHEMOTAXIS; NEUTROPHILIA; PNEUMOCYSTIS PNEUMONIA; PROGNOSIS;

EID: 0030696708     PISSN: 00365548     EISSN: None     Source Type: Journal    
DOI: 10.3109/00365549709011832     Document Type: Article

References (33)

1. Murray JF, Mills J. Pulmonary infectious complications of human immunodeficiency virus infection. Am Rev Respir Dis 141: 1582-98, 1990.
2. Masur H. Prevention and treatment of Pneumocystis pneumonia. N Engl J Med 327: 1853-60, 1992.
3. Limper AH, Offord KP, Smith TF, Martin WJ II. Pneumocystis carinii pneumonia: Differences in lung parasite number and inflammation in patients with and without AIDS. Am Rev Respir Dis 140: 1204-9, 1989.
4. Bentsen KD, Nielsen TL, Eeftinck Schattenkerk JKM, Jensen BN, Lundgren JD. Serum type III procollagen peptide in patients with Pneumocystis carinii infection. Am Rev Respir Dis 148: 1558-62, 1993.
5. Benfield TL, Dichter J, van Steenwijk R, Junge J, Lipschik G, Nielsen TL et al. Interleukin-8 and eicosanoid production in the lungs from patients with Pneumocystis carinii pneumonia and AIDS. Resp Med 89: 285-90, 1995.
6. Bozette SA, Morton SC. Reconsidering the use of adjunctive corticosteroids in Pneumocystis pneumonia. J Acquir Immune Defic Syndr 8: 345-7, 1995.
7. Benfield TL, Prentφ P, Junge J, Vestbo J, Lundgren JD. Alveolar damage in AIDS-associated Pneumocystis carinii pneumonia. Chest 111: 1193-7, 1997.
8. Travis WD, Pittaluga S, Lipschik GY, Ognibene FP, Suffredini AF, Masur H, et al. A typical pathologic manifestation of Pneumocystis carinii pneumonia in the acquired immune deficiency syndrome. Am J Surg Pathol 14: 615-25, 1990.
9. Weber WR, Askin FB, Dehner LP. Lung biopsy in Pneumocystis carinii pneumonia. Am J Clin Pathol 67: 11-19, 1977.
10. Mason GR, Hashimoto CH, Dickman PS, Foutty LF, Cobb CJ. Prognostic implications of bronchoalveolar lavage neutrophilia in patients with Pneumocystis carinii pneumonia and AIDS. Am Rev Respir Dis 139: 1336-42, 1989.
11. Smith RL, el Sadr, WM, Lewis ML. Correlation of bronchoalveolar lavage cell populations with clinical severity of Pneumocystis carinii pneumonia. Chest 93: 60-3, 1988.
12. Vestbo J, Nielsen TL, Junge J, Lundgren JD. Amount of Pneumocystis carinii and degree of acute lung inflammation in HIV-associated P. carinii pneumonia. Chest 104: 109-13, 1993.
13. Weiss S. Tissue destruction by neutrophils . N Engl J Med 320: 365-76, 1989.
14. Peveri P, Walz A, Dewald B, Baggiolini M. A novel neutrophil-activating factor produced by human mononuclear phagocytes. J Exp Med 167: 1547-59, 1988.
15. Larsen CG, Anderson AO, Appela E, Oppenheim JJ, Matsushima K. The neutrophil-activating protein (NAP-1) is also chemotactic for T lymphocytes. Science 243: 1464-6, 1989.
16. Leonard EJ, Skeel A, Yoshimura T, Noer K, Kutvirt S, Van Epps D. Leucocyte specificity and binding of human neutrophil attractant/activating protein-1. J Immun 1323-30 1990.
17. Lipschik GY, Doerfler ME, Kovacs JA, Travis WD, Andrawis VA, Lawrence MG, et al. Leukotriene B4 and interleukin-8 in human immunodeficiency virus-related pulmonary disease. Chest 104: 763-9, 1993.
18. Benfield TL, Vestbo J, Junge J, Nielsen TL, Jensen AMB, Lundgren JD. Prognostic value of interleukin-8 in AIDS-associated Pneumocystis carinii pneumonia. Am J Resp Crit Care Med 151: 1058-62, 1995.
19. Böyum A. Isolation of mononuclear cells and granulocytes from human blood. Scand J Lab Invest 21: 77, 1968.
20. Kharazmi A, Hφiby N, Valerius NH. Effect of antimalarial drugs on human neutrophil chemotaxis in vitro. Acta Pathol Microbiol Immun Scand 91C: 293, 1983.
21. Jensen P, Kharazmi A. Computer-assisted image analysis assay of human neutrophil chemotaxis in vitro. J Immun Methods 144: 43-8, 1991.
22. Ko Y, Mukaida N, Panyutich A, Voitenk NN, Matsushima K, Kawai T, Kasahara T. A sensitive enzyme-linked immunosorbent assay for human interleukin-8. J Immun Meth 149: 227-35, 1991.
23. White MW, Igarashi Y, Lundgren JD, Shelhamer JH, Kaliner M. Hydrocortisone inhibits RBL mediator release induced by neutrophil derived histamine releasing activity as well as by anti-IgE. J Immun 147: 667-73, 1991.
24. 4 production by the human alveolar macrophage: a potential mechanism for amplifying inflammation in the lung. Am Rev Respir Dis 129: 106-11, 1984.
25. McCain RW, Holden EP, Blackwell CP, Christman JW. Leukotriene B4 stimulates human polymorphnuclear leucocytes to synthesize and release interleukin-8 in vitro. Am J Respir Cell Mol Biol 10: 651-7, 1994.
26. Moser B, Clark-Lewis I, Zwahlen R, Baggiolini M. Neutrophil-activating properties of the melanoma growth-stimulatory activity. J Exp Med 171: 1797-802, 1990.
27. Walz A, Burgener R, Car BD, Baggiolini M, Kunkel SL, Strieter RM. Strucure and neutrophil-activating properties of a novel inflammatory peptide (ENA-78) with homology to interleukin-8. J Exp Med 174: 1355-62, 1991.
28. Kurdowska A, Miller EJ, Noble JM, Baughman RP, Matthay MA, Brelsford WG, Cohen AB. Anti-IL-8 auto-antibodies in alveolar fluid from patients with the adult respiratory distress syndrome. J Immun 157: 2699-706, 1996.
29. Goodman RB, Strieter RM, Martin DP, Steinberg KP, Milberg JA, Maunder RJ, et al. Inflammatory cytokines in patients with persistence of the acute respiratory distress syndrome. Am J Respir Crit Care Med 154: 602-11, 1996.
30. Baggiolini M, Walz A, Kunkel SL. Neutrophil-activating peptide-1/interleukin-8, a novel cytokine that activates neutrophils. J Clin Invest 84: 1045-9, 1989.
31. Miller EJ, Cohen AB, Nagao S, Griffith D, Maunder RJ, Martin TJ, et al. Elevated levels of NAP-1/interleukin-8 are present in airspaces of patients with the adult respiratory distress syndrome and are associated with increased mortality. Am Rev Respir Dis 146: 427, 1992.
32. Richman-Eisenstat JBY, Jorens PG, Hébert CA, Ueki I, Nadel JA. Interleukin-8: an important chemoattractant in sputum of patients with chronic inflammatory airway diseases. Am J Physiol 264: L413-8, 1993.
33. Ozaki T, Hayashi H, Tani K, Ogushi F, Yasuoka S, Ogure T. Neutrophil chemotactic factors in the respiratory tract of patients with chronic airway diseases or idiopathic pulmonary fibrosis. Am Rev Respir Dis 145: 85-91, 1992.